197 related articles for article (PubMed ID: 17380320)
1. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.
Ulusoy G; Arinç E; Adali O
Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320
[TBL] [Abstract][Full Text] [Related]
2. Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population.
Kayaaltı Z; Söylemezoğlu T
Alcohol; 2010 Aug; 44(5):415-23. PubMed ID: 20598484
[TBL] [Abstract][Full Text] [Related]
3. Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations.
Goh LP; Chong ET; Chua KH; Chuah JA; Lee PC
Asian Pac J Cancer Prev; 2014; 15(17):7377-81. PubMed ID: 25227845
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of cytochrome P450 2E1 in the Turkish population.
Omer B; Ozbek U; Akköse A; Kiliç G
Cell Biochem Funct; 2001 Dec; 19(4):273-5. PubMed ID: 11746208
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
Sangrajrang S; Jedpiyawongse A; Srivatanakul P
Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in iranian populations.
Shahriary GM; Galehdari H; Jalali A; Zanganeh F; Alavi SM; Aghanoori MR
Asian Pac J Cancer Prev; 2012; 13(12):6505-10. PubMed ID: 23464483
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases.
Zgheib NK; Mitri Z; Geryess E; Noutsi P
Genet Test Mol Biomarkers; 2010 Jun; 14(3):393-7. PubMed ID: 20406102
[TBL] [Abstract][Full Text] [Related]
8. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro.
Rossini A; Lima SS; Rapozo DC; Faria M; Albano RM; Pinto LF
Braz J Med Biol Res; 2006 Feb; 39(2):195-201. PubMed ID: 16470306
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
[TBL] [Abstract][Full Text] [Related]
10. Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia.
Ulusoy G; Adali O; Tumer TB; Sahin G; Gozdasoglu S; Arinç E
Oncology; 2007; 72(1-2):125-31. PubMed ID: 18025800
[TBL] [Abstract][Full Text] [Related]
11. Functional PstI/RsaI polymorphisms in the CYP2E1 gene among south Indian populations.
Lakkakula S; Maram R; Munirajan AK; Pathapati RM; Visveswara SB; Lakkakula BV
Asian Pac J Cancer Prev; 2013; 14(1):179-82. PubMed ID: 23534720
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of genes coding to alcohol-metabolizing enzymes in western Mexicans: association of CYP2E1*c2/CYP2E1*5B allele with cirrhosis and liver function.
García-Bañuelos J; Panduro A; Gordillo-Bastidas D; Gordillo-Bastidas E; Muñoz-Valle JF; Gurrola-Díaz CM; Sánchez-Enríquez S; Ruiz-Madrigal B; Bastidas-Ramírez BE
Alcohol Clin Exp Res; 2012 Mar; 36(3):425-31. PubMed ID: 21895718
[TBL] [Abstract][Full Text] [Related]
16. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
17. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
18. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
19. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
[TBL] [Abstract][Full Text] [Related]
20. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.
Wang SM; Zhu AP; Li D; Wang Z; Zhang P; Zhang GL
J Hum Genet; 2009 Jun; 54(6):372-5. PubMed ID: 19444287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
